By S. Mangiacotti, GE Healthcare Life Sciences, and T. Marshall, Zenith Technologies
Over the last decade, the pharmaceutical industry has seen a dramatic evolution of its traditional business model. Rather than relying on blockbuster drugs that offer a substantial payoff, today’s companies are intensifying their efforts to generate targeted drug candidates to support personalized medicine and combinatorial therapies. Not only does this evolution call for new and innovative approaches to drug pipeline development, but it also increases the need for operational efficiency. Now, greater speed, productivity, and accuracy have gone from being just advantages in a complex manufacturing environment to requirements, leading to more investments in technology and automation.
However, integrating automation in a biomanufacturing environment successfully can become a daunting task without the right preparation and a clear implementation strategy. Through proper planning, you can eliminate costly errors and missteps and focus on developing efficient, future-proof automation strategies.